Israel says Pfizer vaccine effectiveness against Covid-19 down to 64%

The effectiveness of the Pfizer vaccine against Covid-19 has dropped to 64 per cent in Israel, the country's Ministry of Health said.

Pfizer Vaccine, Coronavirus vaccine
Photo: Shutterstock
IANS Tel Aviv
1 min read Last Updated : Jul 06 2021 | 9:47 AM IST

The effectiveness of the Pfizer vaccine against Covid-19 has dropped to 64 per cent in Israel, the country's Ministry of Health said.

The new figure refers to the period between June 6 and July 3, and it is significantly lower than the effectiveness rate of 94.3 percent in protection against infection, measured between May 2 and June 5, Xinhua news agency quoted the Ministry as saying on Monday.

It noted that the decline was observed along with the spread of the Delta Covid-19 variant in Israel.

However, the effectiveness of the vaccine in preventing hospitalisations and severe coronavirus disease is currently estimated at 93 per cent in Israel.

The Ministry currently promotes the administration of a third vaccine dose to those who have suffered a functional decline in the immune system, but there is currently no decision to launch a third dose campaign for the entire population.

Since the start of the vaccination campaign in Israel on December 20, 2020, over 5.65 million people, or 60.6 per cent of the population, have received the first dose of the vaccine, while 5.18 million have received the second dose.

--IANS

ksk/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :PfizerCoronavirus Vaccineisrael

First Published: Jul 06 2021 | 9:47 AM IST

Next Story